Shanghai Shenqi Pharmaceutical Investment Management Co Ltd
SSE:600613
Balance Sheet
Balance Sheet Decomposition
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd
Balance Sheet
Shanghai Shenqi Pharmaceutical Investment Management Co Ltd
| Dec-2001 | Dec-2002 | Dec-2003 | Dec-2004 | Dec-2005 | Dec-2006 | Dec-2007 | Dec-2008 | Dec-2009 | Dec-2010 | Dec-2011 | Dec-2012 | Dec-2013 | Dec-2014 | Dec-2015 | Dec-2016 | Dec-2017 | Dec-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||||||||
| Cash & Cash Equivalents |
28
|
9
|
8
|
40
|
6
|
11
|
3
|
5
|
14
|
27
|
23
|
31
|
328
|
297
|
264
|
309
|
284
|
206
|
596
|
482
|
494
|
655
|
714
|
779
|
|
| Cash |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
1
|
0
|
1
|
0
|
0
|
494
|
655
|
714
|
779
|
|
| Cash Equivalents |
28
|
9
|
8
|
40
|
6
|
11
|
3
|
5
|
14
|
27
|
23
|
31
|
326
|
296
|
263
|
309
|
284
|
205
|
596
|
481
|
0
|
0
|
0
|
0
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
21
|
21
|
|
| Total Receivables |
85
|
20
|
23
|
105
|
89
|
99
|
108
|
94
|
110
|
83
|
113
|
431
|
676
|
853
|
1 120
|
1 221
|
1 252
|
1 259
|
1 092
|
712
|
714
|
829
|
764
|
538
|
|
| Accounts Receivables |
20
|
5
|
9
|
63
|
49
|
51
|
58
|
51
|
46
|
32
|
40
|
131
|
338
|
503
|
644
|
852
|
913
|
870
|
776
|
487
|
455
|
361
|
393
|
323
|
|
| Other Receivables |
64
|
16
|
15
|
42
|
39
|
49
|
50
|
43
|
64
|
51
|
73
|
300
|
339
|
350
|
476
|
368
|
339
|
390
|
315
|
225
|
258
|
467
|
370
|
215
|
|
| Inventory |
4
|
18
|
15
|
14
|
10
|
6
|
5
|
5
|
4
|
5
|
10
|
53
|
85
|
151
|
174
|
208
|
208
|
175
|
161
|
204
|
205
|
219
|
243
|
228
|
|
| Other Current Assets |
0
|
0
|
0
|
1
|
1
|
9
|
16
|
5
|
3
|
1
|
0
|
4
|
26
|
89
|
36
|
146
|
83
|
98
|
31
|
34
|
33
|
68
|
31
|
29
|
|
| Total Current Assets |
117
|
47
|
46
|
160
|
106
|
125
|
133
|
109
|
129
|
116
|
146
|
518
|
1 115
|
1 389
|
1 593
|
1 884
|
1 827
|
1 739
|
1 879
|
1 431
|
1 446
|
1 770
|
1 772
|
1 596
|
|
| PP&E Net |
21
|
54
|
43
|
141
|
134
|
126
|
118
|
108
|
100
|
92
|
84
|
151
|
335
|
371
|
430
|
465
|
556
|
688
|
825
|
960
|
1 167
|
1 105
|
1 056
|
1 062
|
|
| PP&E Gross |
21
|
54
|
43
|
141
|
134
|
126
|
118
|
108
|
100
|
92
|
84
|
151
|
335
|
371
|
430
|
465
|
556
|
688
|
825
|
960
|
1 167
|
1 105
|
1 056
|
1 062
|
|
| Accumulated Depreciation |
8
|
11
|
9
|
23
|
33
|
42
|
52
|
61
|
72
|
81
|
90
|
208
|
265
|
295
|
328
|
368
|
403
|
428
|
463
|
506
|
588
|
672
|
750
|
822
|
|
| Intangible Assets |
4
|
9
|
8
|
43
|
38
|
32
|
32
|
32
|
0
|
0
|
0
|
10
|
109
|
56
|
108
|
113
|
121
|
125
|
118
|
111
|
105
|
99
|
95
|
97
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
412
|
412
|
412
|
412
|
461
|
461
|
461
|
299
|
299
|
299
|
244
|
244
|
|
| Note Receivable |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
10
|
0
|
0
|
0
|
|
| Long-Term Investments |
171
|
127
|
118
|
17
|
17
|
10
|
11
|
11
|
11
|
11
|
11
|
11
|
22
|
23
|
121
|
120
|
113
|
96
|
82
|
94
|
92
|
75
|
82
|
93
|
|
| Other Long-Term Assets |
96
|
85
|
75
|
0
|
0
|
1
|
1
|
2
|
4
|
2
|
2
|
2
|
3
|
4
|
8
|
11
|
17
|
19
|
191
|
203
|
31
|
38
|
30
|
25
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
412
|
412
|
412
|
412
|
461
|
461
|
461
|
299
|
299
|
299
|
244
|
244
|
|
| Total Assets |
409
N/A
|
322
-21%
|
290
-10%
|
361
+24%
|
295
-18%
|
295
N/A
|
295
0%
|
262
-11%
|
244
-7%
|
221
-10%
|
243
+10%
|
691
+184%
|
1 995
+189%
|
2 254
+13%
|
2 671
+19%
|
3 003
+12%
|
3 096
+3%
|
3 127
+1%
|
3 556
+14%
|
3 098
-13%
|
3 149
+2%
|
3 386
+8%
|
3 279
-3%
|
3 116
-5%
|
|
| Liabilities | |||||||||||||||||||||||||
| Accounts Payable |
7
|
3
|
3
|
21
|
6
|
7
|
8
|
7
|
5
|
3
|
5
|
31
|
60
|
73
|
103
|
95
|
138
|
181
|
163
|
151
|
188
|
187
|
250
|
224
|
|
| Accrued Liabilities |
20
|
28
|
50
|
24
|
34
|
16
|
22
|
10
|
17
|
14
|
0
|
0
|
26
|
27
|
59
|
66
|
49
|
40
|
36
|
24
|
32
|
61
|
36
|
34
|
|
| Short-Term Debt |
129
|
99
|
74
|
90
|
36
|
59
|
40
|
20
|
20
|
0
|
0
|
79
|
0
|
30
|
42
|
109
|
130
|
0
|
130
|
3
|
105
|
351
|
258
|
100
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
37
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
25
|
45
|
44
|
48
|
50
|
|
| Other Current Liabilities |
2
|
13
|
12
|
49
|
34
|
23
|
21
|
16
|
16
|
11
|
26
|
30
|
95
|
124
|
153
|
276
|
230
|
266
|
254
|
255
|
110
|
132
|
94
|
123
|
|
| Total Current Liabilities |
157
|
143
|
140
|
183
|
110
|
105
|
90
|
53
|
58
|
29
|
32
|
177
|
181
|
254
|
358
|
546
|
546
|
487
|
584
|
457
|
480
|
774
|
686
|
531
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
30
|
0
|
0
|
0
|
0
|
0
|
0
|
239
|
286
|
258
|
220
|
187
|
140
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
26
|
20
|
17
|
12
|
16
|
16
|
16
|
18
|
14
|
16
|
|
| Minority Interest |
10
|
10
|
10
|
17
|
18
|
18
|
19
|
20
|
18
|
19
|
20
|
22
|
26
|
32
|
56
|
76
|
67
|
59
|
45
|
50
|
48
|
45
|
55
|
64
|
|
| Other Liabilities |
0
|
0
|
0
|
2
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
2
|
2
|
2
|
3
|
28
|
56
|
11
|
3
|
2
|
1
|
2
|
|
| Total Liabilities |
167
N/A
|
154
-8%
|
150
-2%
|
202
+34%
|
127
-37%
|
124
-3%
|
109
-12%
|
73
-34%
|
76
+4%
|
47
-38%
|
52
+10%
|
229
+342%
|
210
-8%
|
288
+37%
|
441
+53%
|
644
+46%
|
633
-2%
|
587
-7%
|
939
+60%
|
821
-13%
|
805
-2%
|
1 059
+32%
|
944
-11%
|
753
-20%
|
|
| Equity | |||||||||||||||||||||||||
| Common Stock |
148
|
148
|
148
|
148
|
148
|
148
|
148
|
148
|
148
|
148
|
148
|
148
|
445
|
445
|
534
|
534
|
534
|
534
|
534
|
534
|
534
|
534
|
534
|
534
|
|
| Retained Earnings |
46
|
120
|
148
|
162
|
5
|
1
|
13
|
17
|
4
|
2
|
20
|
171
|
282
|
462
|
651
|
797
|
911
|
1 001
|
1 085
|
744
|
813
|
808
|
811
|
829
|
|
| Additional Paid In Capital |
141
|
141
|
141
|
174
|
24
|
24
|
24
|
24
|
24
|
24
|
24
|
144
|
1 058
|
1 058
|
969
|
969
|
969
|
969
|
969
|
969
|
969
|
969
|
969
|
969
|
|
| Unrealized Security Profit/Loss |
0
|
1
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
16
|
21
|
31
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
76
|
58
|
49
|
36
|
29
|
31
|
28
|
16
|
0
|
0
|
|
| Total Equity |
242
N/A
|
168
-31%
|
140
-17%
|
159
+14%
|
167
+5%
|
171
+2%
|
185
+8%
|
189
+2%
|
168
-11%
|
174
+3%
|
191
+10%
|
463
+142%
|
1 786
+286%
|
1 966
+10%
|
2 230
+13%
|
2 359
+6%
|
2 463
+4%
|
2 540
+3%
|
2 617
+3%
|
2 277
-13%
|
2 344
+3%
|
2 327
-1%
|
2 335
+0%
|
2 363
+1%
|
|
| Total Liabilities & Equity |
409
N/A
|
322
-21%
|
290
-10%
|
361
+24%
|
295
-18%
|
295
N/A
|
295
0%
|
262
-11%
|
244
-7%
|
221
-10%
|
243
+10%
|
691
+184%
|
1 995
+189%
|
2 254
+13%
|
2 671
+19%
|
3 003
+12%
|
3 096
+3%
|
3 127
+1%
|
3 556
+14%
|
3 098
-13%
|
3 149
+2%
|
3 386
+8%
|
3 279
-3%
|
3 116
-5%
|
|
| Shares Outstanding | |||||||||||||||||||||||||
| Common Shares Outstanding |
178
|
178
|
178
|
178
|
178
|
178
|
178
|
178
|
178
|
178
|
178
|
300
|
534
|
534
|
534
|
534
|
534
|
534
|
534
|
534
|
534
|
534
|
534
|
534
|
|